• Are Higher Doses of HMG-CoA Reductase Inhibitors Cost-Effective?
• Do Statin Drugs Reduce the Risk of Stroke and Total Mortality?
• Does Stress Cause Carotid Atherosclerosis in Women? - Sep 98
• Lipoprotein(a) Does Not Act Alone in Heart Disease
• What is the Potential of Antioxidant Vitamins to Prevent Atherosclerosis?
• What is the Relationship Between Parental CAD and Cardiac Risk Factors Developed During Early Adulthood?

DRUG Infoline

• Benecol: A Cholesterol-lowering Margarine - Jun 99
• FDA Approves Welchol for Hypercholesterolemia - prof'l version; 19 June 2000
• FDA Approves Welchol for High Cholesterol - consumer version; 19 June 2000
• Statin Drugs Reduce Fracture Risk and Increase Bone Density, Studies Report - prof'l version; 17 July 2000
• Statin Drugs Reduce Fracture Risk and Increase Bone Density, Studies Report - consumer version; 17 July 2000

Med-Brief

• Drug treatment of inherited high cholesterol disorder in adolescents - Jan 99
• New findings on cholesterol-lowering drug - Sep 99

Medical Sciences Bulletin

• Assessing Cholesterol- lowering Therapy
• Atorvastatin for Reduction of Elevated Cholesterol
• Benecol: A Cholesterol-lowering Margarine
• Cerivastatin for the Reduction of Elevated Total Cholesterol
• Cholesterol, Atherosclerosis, and Coronary Heart Disease
• Fluvastatin for Hypercholesterolemia
• Focus On... Apolipoproteins
• Focus On... The "Statins" and the Heart
• Lipid-Lowering Effects of Red Yeast Rice
• Preventing Secondary Cardiac Attacks in Women - May/June 1998
• Red Wine Polyphenols Block Fat Oxidation - Nov 98
• Simvastatin: Preventing MI
• Take Charge, Take Heart -- Take Walnuts
• The Toxicity of Niacin
• Vitamin E and the Risk of Coronary Artery Disease

• Niacin: Letter to Editor

• WARNING LABELING CHANGES FOR NEW HEART DRUG POSICOR

PNN Pharmacotherapy Line

• Cholesterol Lowering: Carcinogenic or Not?
• Project ImPACT Results Exceed National Averages- Mar 00
• Raloxifene: Favorable Effects on Lipids, Clotting
• Stroke Reduced 29% by Statin Agents
• Women Need Agreesive Cholesterol Therapy, Too

Medical Meeting Highlights

• ASH95: METABOLIC ISSUES AND TREATMENT OF HYPERTENSION
• ASH96: Estrogen and cardiovascular disease: an overview

Press Releases

• FDA CLEARS PRAVACHOL TO REDUCE RISK OF HEART ATTACK
• FDA CLEARS PRAVACHOL TO HELP PREVENT FIRST HEART ATTACK
• PRAVACHOL REDUCES RISK OF RECURRENT HEART ATTACK AND DEATH
• New Cholesterol-Lowering Agent From Bayer Cleared By FDA

Cardio-Consult Archives

• Cholesterol levels after MI
• Debate on CARE Trial Results

• atorvastatin (Lipitor)
• cerivastatin (Baychol)
• colesevelam (Welchol)
• fluvastatin (Lescol)
• lovastatin (Mevacor)
• pravastatin (Pravachol)
• simvastatin (Zocor)

Web Sites

The American Heart Association

American College of Cardiology

National Heart, Lung, and Blood Institute

Cyberounds Cardiovascular Medicine

PharmInfoNet's Cardiovascular Disease Center

Email Lists and Discussion Groups

• CARDIO-CONSULT

  CARDIO-CONSULT is an EXCLUSIVE email network for healthcare professionals, physicians and surgeons in the cardiovascular field.

  CARDIO-CONSULT facilitates peer-to-peer communication between members and recognized experts and leaders in cardiovascular medicine. For example, CARDIO-CONSULT sponsors TOPICS FOR DISCUSSION, which are hosted by individual members of the list or guest editors. Topics may include actual case studies that could benefit from peer-to-peer input from members of CARDIO-CONSULT or challenging didactic case studies that stimulate discussion focused on particular therapies.

© 2000 Mediconsult.com, Limited. All rights reserved. As seen on PharmInfoNet ()